Received: by alpheratz.cpm.aca.mmu.ac.uk id RAA21920 (8.6.9/5.3[ref pg@gmsl.co.uk] for cpm.aca.mmu.ac.uk from fmb-majordomo@mmu.ac.uk); Wed, 6 Feb 2002 17:49:53 GMT Date: Wed, 6 Feb 2002 12:43:51 -0500 Content-Type: text/plain; charset=ISO-8859-1; format=flowed Subject: Fwd: Gut Thoughts From: Wade Smith <wade_smith@harvard.edu> To: memetics@mmu.ac.uk, Skeptic List <skeptic@listproc.hcf.jhu.edu> Content-Transfer-Encoding: quoted-printable Message-Id: <15B7DC9B-1B29-11D6-9DC1-003065A0F24C@harvard.edu> X-Mailer: Apple Mail (2.480) Sender: fmb-majordomo@mmu.ac.uk Precedence: bulk Reply-To: memetics@mmu.ac.uk
Gut Thoughts
by Maia Szalavitz
        
Posted February 1, 2002 · Issue 119
------------------------------------------------------------------------
Abstract
Though few know about it, humans have a second brain that 
handles most of the body's digestive functions. Study of the 
enteric nervous system is a rapidly growing specialty, offering 
insight into malfunctions of the "gut brain" as well as the more 
complex cranial brain.
------------------------------------------------------------------------
Digestion is such a prosaic function that most people prefer not 
to think about it. Fortunately, they don't have to - at least 
not with the brain in their heads. Though few know about it, 
humans (and other animals) have a second brain that handles most 
digestive functions.
Deep in your gut lies a complex self-contained nervous system 
containing more nerve cells than the spinal cord, and indeed 
more neurons than all the rest of the peripheral nervous system. 
There are over 100 million nerve cells in the human small 
intestine alone.
Malfunctions of this "gut brain" may be involved in irritable 
bowel syndrome (IBS), a condition that affects an estimated 20 
percent of the U.S. population and is believed to be responsible 
for $8 billion in health care costs alone in the United States 
each year, according to the International Foundation for 
Functional Gastrointestinal Disorders. Patients with IBS suffer 
bouts of chronic diarrhea, constipation, or sometimes both 
alternately. IBS is the most common diagnosis made by 
gastroenterologists.
The study of the enteric nervous system is a rapidly growing 
specialty known as neurogastroenterology.
"What the gut has to do is extremely complicated," says Michael 
Gershon, chair of the department of anatomy and cell biology at 
the Columbia University College of Physicians and Surgeons and 
author of The Second Brain (Harper Perennial, 1999). "If the 
brain had to control that, it would have to run huge cables and 
have a huge number of cells devoted solely to that purpose. It 
makes great evolutionary sense to [separate these functions] and 
essentially use a microcomputer that is independent rather than 
a central processing unit."
In fact, researchers believe that the gut brain evolved first - 
because digestion came before locomotion in multicellular 
creatures. In mammals, the two systems originate near each other 
in the outer layer of the early embryo.
Like many poorly understood organs, the gut brain was discovered 
by classical anatomists in the 19th century and then ignored. 
"No one knew what it did," says David Wingate, emeritus 
professor of gastrointestinal science at Queen Mary, University 
of London. "When you'd ask what it was for in medical school, 
they'd say, 'Let's move on.'"
In 1899, physiologists studying dogs found that unlike any other 
reflex, the continuous push of material through the digestive 
system (now called the peristaltic reflex) continued when nerves 
linking the brain to the intestines were cut.
By the 1970s, a society for the study of gastrointestinal 
motility had been set up - but how this motility was controlled 
remained unclear. The vagus nerve, for example, sends some 
fibers from the brain to the gut; however, it connects directly 
with only a tiny minority of cells there.
In 1965, Gershon published a paper in Science suggesting that 
serotonin might act as a neurotransmitter in the gut. At the 
time, acetylcholine and norepinephrine were accepted as 
transmitters in the peripheral nervous system, but serotonin was 
seen as a centrally acting transmitter used by some nerves to 
modulate the action of others.
The peripheral nervous system wasn't supposed to use such 
controls - only the brain and spinal cord were believed to 
process information through "interneurons" such as those 
containing serotonin.
At a meeting of the Society for Neuroscience in 1981, however, 
Gershon and others marshaled enough data to finally convince 
skeptics that serotonin was indeed a key transmitter in the gut.
In fact, it is now known that 95% of the body's serotonin is 
used by the gut - and the enteric nervous system contains every 
neurotransmitter and neuromodulator found so far in the brain.
"We now know quite a lot about the library of programs run by 
the [gut brain]," says Jackie Wood, professor of physiology and 
cell biology and of internal medicine at Ohio State University. 
"For example, when the bowel is empty, one particular program 
runs." Called the migrating motor complex (MMC), this involves a 
series of movements running from the stomach to the end of the 
small intestine, which is believed to function in keeping the 
potentially dangerous bacteria stored in the colon from moving 
upwards rather than out.
At least 500 different species of deadly bacteria have been 
found to inhabit a person's colon at any given time; "traveler's 
diarrhea" often results when this mix is changed through 
exposure to new pathogens. If this happens, the gut runs a 
program designed to expel as much of its contents as quickly as 
possible - unpleasant for the vacationer, but much better than a 
fatal infection.
"Another program involves a flood of serotonin throughout the 
entire circuit, which produces the digestive pattern that mixes 
and stirs the contents," says Wood.
Because the gut brain is smaller and more accessible than the 
brain itself, understanding it could offer insights about how to 
parse the more complex organ. "[That idea] was what lead me to 
begin my research when I was a fledgling neuroscientist," says 
Gershon. "I looked at the brain and found it daunting, and I 
still do, so I looked for a simpler nervous system to study." He 
adds, "'Simple nervous system,' of course, turned out to be an 
oxymoron."
Unlike the cranial brain, however, the gut brain doesn't seem to 
be conscious - or at least, in health, it doesn't impinge much 
on consciousness. "The gut is not an organ from which you like 
to receive frequent progress reports," says Gershon. For most 
digestive processes, no news is good news.
The problem in IBS, in fact, may be that the enteric nervous 
system becomes overly sensitive to normal functioning and 
reports to the brain when it shouldn't. Or, the brain may 
overreact to normal bowel signals.
Normally, the brain may avoid conscious awareness of most gut 
activity. But in IBS, says Wingate, one theory is that "the 
barrier to information being projected into consciousness is 
lowered."
As in many heterogeneous conditions defined by symptoms rather 
than specific pathology, different subgroups of patients may 
have different causes or varying levels of contributions by 
different factors.
In some cases, IBS may be an autoimmune problem - something like 
multiple sclerosis of the gut, where immune cells attack nervous 
tissue. "If you catch it early enough," says Wood, "You can use 
steroids to treat it [in such cases]." High doses of steroids 
shut down immune activity and prevent immune cells from causing 
harm, but they don't help once damage has been done.
The gut is, in fact, a major immune organ, containing more 
immune cells than the rest of the body combined. The enteric 
nervous system interacts intimately with the immune system, and 
can affect mood and behavior by signaling the central nervous 
system.
Further, the gut brain may in fact be the only system that can 
refuse central signals. Says Gershon, "The gut brain can say no 
to the big brain, absolutely. In fact, there are nerve fibers 
that project towards the CNS, and if the [bowel] doesn't like 
the message, it can turn it off or cancel it."
Indeed, the vagus nerve mostly carries information from the 
enteric nervous system to the brain - for every one message sent 
by the brain to the gut, about nine are sent in the other 
direction. And recent research has found that stimulating this 
nerve can have antidepressant and even learning-enhancing 
effects - so "gut feelings" could genuinely be more than just a 
metaphor.
The similarities between the two nervous systems may also mean 
that they are vulnerable to similar toxins and disease 
processes. For example, in both Parkinson's disease and 
Alzheimer's, the degenerative processes seen in brain nerve 
cells are also seen in the neurons of the enteric system.
This link could also help explain the connection between 
psychological problems and gut problems - and could put to rest 
the myth that problems such as IBS are simply "neuroses" because 
they so often occur in people with other psychological disorders.
It may be that the real reason that bowel disorders often 
accompany psychological problems is that both brain and gut 
neurons are suffering simultaneously - in addition to the fact 
that having to spend a significant portion of one's life 
attending to bathroom functions is in itself depressing.
Simultaneous effects of drugs on both systems also account for 
the gastrointestinal "side effects" of Prozac and other drugs 
that act on serotonin metabolism - which actually may have more 
effect on the bowel than on the brain, because serotonin 
predominates in the bowel and the drug moves through the 
digestive system before reaching the brain.
Fortunately, in most people, the bowel quickly develops 
tolerance to these drugs, and gastrointestinal side effects 
usually subside within a few days or weeks of the start of 
treatment. In fact, low doses of SSRI (selective serotonin 
reuptake inhibitor) drugs may actually help patients with IBS. 
And since different serotonin receptors predominate in the brain 
and in the gut, new drugs may be developed to affect certain 
subtypes but not others.
"What's exciting," says Wingate, "is getting away from 
essentially anecdotal ways of categorizing patients by symptoms 
and being able to study [their problems] in a very systematic 
biological way."
Maia Szalavitz is a health/science journalist who has written 
for the New York Times, the Washington Post, Newsday, New York 
Magazine, Salon, and other major publications.
===============================This was distributed via the memetics list associated with the
Journal of Memetics - Evolutionary Models of Information Transmission
For information about the journal and the list (e.g. unsubscribing)
see: http://www.cpm.mmu.ac.uk/jom-emit
This archive was generated by hypermail 2b29 : Wed Feb 06 2002 - 18:04:02 GMT